Encompass Health Corporation EHC

123.47 1.46 1.20% as of 25 Sep
Market cap
$12.0B
P/E
19.9×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
6,206.10 6,066.40 5,935.20 5,795.60

+8 more TTM periods

Gross Profit
6,206.10 6,066.40 5,935.20 5,795.60
SG&A Expenses
3,729.10 3,670.30 3,606.50 3,546.10
Operating Income
1,113.60 1,087.50 1,053.10 1,001.40
Non-operating Income/Expense
(85.70) (84.40) (100.10) (104.70)
Non-operating Interest Expenses
125.60 123.20 123.20 126.00
EBT
1,027.90 1,003.10 953.00 896.70
Income Tax Provision
210.30 207.70 192.90 175.10
Income after Tax
817.60 795.40 760.10 721.60
Net Income Common
621.00 609.20 566.20 540.60
EPS (Basic)
6.22 6.08 5.63 5.39
Gross Margin
100.00% 100.00% 100.00% 100.00%
EBIT Margin
17.94% 17.93% 17.74% 17.28%
EBT margin
16.56% 16.54% 16.06% 15.47%
Net Profit Margin
10.01% 10.04% 9.54% 9.33%
Free Cash Flow Margin
6.66% 7.66% 7.40% 6.95%
EBITDA
1,469.70 1,433.10 1,390.60 1,330.60
EBIT
1,113.60 1,087.50 1,053.10 1,001.40
EPS (Diluted, from Cont. Ops)
5.99 5.84 5.55 5.30
EPS (Diluted, from Disc. Ops)
0.00 0.00 0.00 0.00
EPS (Basic, Consolidated)
8.36 8.10 7.55 7.17
EPS (Basic, from Discontinued Ops)
0.16 0.16 (0.01) (0.01)
EPS (Basic, from Continuous Ops)
6.07 5.93 5.63 5.38
Income from Continuous Operations
817.60 795.40 760.10 721.60
Income from Discontinued Operations
15.70 15.40 (1.00) (1.40)
Consolidated Net Income/Loss
833.30 810.80 759.10 720.20
EBITDA Margin
23.68% 23.62% 23.43% 22.96%
Operating Cash Flow Margin
19.54% 19.78% 19.81% 19.12%

Fold the line items

In millions of $ except per-share values · columns are period end dates